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etrospective studies, using prolactin (PRL)
response to d-fenfluramine test (d-FEN; a presynaptic
serotonin [5-hydroxytryptamine, 5-HT]–releasing and
–uptake-inhibiting agent), have suggested that reduced
serotonergic functioning may be a marker of increased sui-
cide risk in patients with major depression
1 and schizo-
phrenia.
2 The etiology of this abnormality remains
unknown,but it has been suggested
3 that overactivation of
the hypothalamic-pituitary-adrenal (HPA) axis by chronic
stress,and the associated hypercortisolism,could directly
induce changes in 5-HT pathways. Consequently, it has
been hypothesized that 5-HT abnormality in patients with
a history of suicidal behavior could be secondary to hyper-
activity of the HPA axis.
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Disturbances in the serotonin (5-hydroxytryptamine, 5-HT) system constitute the neurobiological abnormality most con-
sistently associated with suicide. This abnormality could be a marker of vulnerability predisposing individuals to auto-
aggressive and impulsive behavior. However, other abnormalities, such as hyperactivity of the hypothalamic-pituitary-
adrenal (HPA) axis, have also been described in suicide victims. While inhibitory effects of adrenocorticosteroids on 5-HT1A
receptor function have been shown in animals, HPA axis hyperactivity does not seem to be responsible for the reduced 5-
HT activity found in depressed patients with a history of suicidal behavior. On the other hand, hypothalamic-pituitary-
thyroid (HPT) axis dysfunction, frequently observed in depression, may represent a compensatory response to reduced
central 5-HT neurotransmission. Moreover, in depressed patients with a history of suicidal behavior, the absence of a func-
tional link between HPT and dopamine activity at the hypothalamic level may be implicated in the pathophysiology of
suicidal behavior. Future research is needed to determine why compensatory mechanisms are not efficient in patients
with suicidal behavior. Dialogues Clin Neurosci. 2002;4:417-425.The hypothesis of hyperactivity of the HPA is supported
by the postmortem findings of increased cerebrospinal
fluid (CSF) corticotropin-releasing hormone (CRH) con-
centrations and reduced CRH receptor binding sites in the
frontal cortex of suicide victims (interpreted as downreg-
ulation following CRH hypersecretion) and dexametha-
sone nonsuppression in some, but not all, suicide
attempters.
4While there is evidence for inhibitory effects
of the HPA on 5-HT activity in animals,studies in healthy
humans and depressed patients have produced disparate
findings.It has been reported,in small samples,that acute
treatment with hydrocortisone attenuates PRL response
to d-FEN,
5 though subchronic administration of hydro-
cortisone induces no change in PRL response to d-FEN.
6
It has also been found that pretreatment with dexa-
methasone decreases cortisol—but not PRL—response
to d-FEN.
7 In depression, some authors have hypothe-
sized
8,9 that raised cortisol levels could lead to impaired
neuroendocrine responses to the d-FEN challenge.This
modification could be related more specifically to blunted
5-HT1A receptor function,rather than to reduced 5-HT
presynaptic release or 5-HT2 receptor function.Indeed,
preclinical studies have shown that chronic hypercorti-
solemia inhibits 5-HT1A receptor function, while 5-HT
turnover and 5-HT2 receptor function are enhanced.
10
Lack of effect of HPA hyperactivity on 5-HT
responsiveness in depressed patients
In a recent study,
11 we have examined the relationship
between HPA axis activity and 5-HT function in major
depression,particularly in patients with a history of suici-
dal behavior.We measured (i) cortisol levels at baseline
and following dexamethasone suppression test (DST;1 mg
orally administered at midnight on day 1);and (ii) PRL,
adrenocorticotropic hormone (ACTH), and cortisol
responses to challenge with d-FEN (45 mg orally,at 9 AM
on day 5) in 71 drug-free Diagnostic and Statistical Manual
of Mental Disorders, Fourth Edition (DSM-IV)
12 major
depressed inpatients (40 with a history of suicide attempt,
31 without) and 34 hospitalized healthy control subjects.
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Selected abbreviations and acronyms
ACTH adrenocorticotropic hormone
APO apomorphine
CRH corticotropin-releasing hormone
DA dopamine
d-FEN d-fenfluramine
DST dexamethasone suppression test 
GH growth hormone
HPA hypothalamic-pituitary-adrenal (axis)
HPT hypothalamic-pituitary-thyroid (axis)
5-HT 5-hydroxytryptamine (serotonin) 
PRL prolactin
TRH thyrotropin-releasing hormone
TSH thyroid-stimulating hormone
Table I. Demographic characteristics and biological data for depressed patients and normal control subjects. DST, dexamethasone suppression test;
No. of abnormal DSTs, number of subjects with highest post-DST cortisol level >130 nmol/L; ∆, peak concentration minus baseline value; PRL,
prolactin; ACTH, adrenocorticotropic hormone.
Control subjects (n=34) Depressed patients (n=71) P
Mean (SEM) Mean (SEM)
Age (years) 39.6 (1.6) 40.2 (1.1) 0.81
Range (years) 20-63 19-60
Gender (M/F) 14/20 28/43 0.86
Weight (kg) 66.5 (1.5) 65.5 (1.4) 0.80
Range (kg) 47-90 42-93
Post-DST cortisol (nmol/L) 38 (4) 98 (12) 0.003
No. of abnormal DSTs 1 19 0.008
Fenfluramine test
• Baseline PRL (µg/L) 12.4 (0.9) 14.5 (1.1) 0.73
• ∆PRL (µg/L) 5.5 (0.8) 4.3 (1.3) 0.09
• Baseline ACTH (ng/L) 25.5 (3.1) 24.7 (2.0) 0.98
• ∆ACTH (ng/L) 11.2 (4.6) 8.1 (1.2) 0.57
• Baseline cortisol (nmol/L) 358 (20) 378 (21) 0.90
• ∆Cortisol (nmol/L) 88 (27) 83 (18) 0.74We hypothesized that,if HPA overactivity is at the origin
of reduced 5-HT function, high cortisol levels (basal or
post-DST) would be associated with low hormonal
responses to d-FEN.
Depressed patients had higher post-DST cortisol levels
(Table I),but similar responses to d-FEN compared with
control subjects.Hormonal responses to d-FEN were not
correlated with cortisol levels (basal or post-DST).Among
depressed patients, DST suppressors and DST nonsup-
pressors exhibited no significant difference in endocrine
response to d-FEN.Patients were subsequently classified
according to their basal cortisol values (ie,>550 nmol/L).
When patients with high basal cortisol values (n=10) were
compared with patients with normal basal cortisol values
(n=61), they showed no significant difference in post–
d-FEN values.These results suggest that high cortisol lev-
els (at baseline or post-DST) have no significant effect on
PRL or ACTH/cortisol responses to d-FEN.
In our sample,DST nonsuppression was associated with
psychotic depression (P<0.0008),increased age (P<0.004),
and global severity of depression (P<0.04).Although the
exact pathophysiology underlying DST suppression
remains unclear,it has been suggested that abnormal cor-
tisol response reflects impaired negative feedback (at the
level of the pituitary corticotroph) on endogenous HPA
axis hyperactivity (ie, increase in hypothalamic corti-
cotropin-releasing factor and vasopressin drive that over-
rides the action of dexamethasone).
13
When patients with a history of suicide attempt were com-
pared with patients without such a history,they showed
lower hormonal responses to d-FEN, but comparable
basal and post-DST cortisol levels (Table II). Taken
together these results suggest that (i) increased HPA axis
activity does not impair the ability of the brain’s 5-HT sys-
tem to respond normally;and consequently (ii) increased
HPA axis activity is not at the origin of reduced 5-HT
activity observed in a subgroup of depressed patients with
a history of suicide attempts.
However,given the pharmacological properties of d-FEN,
the extent of response to this compound,which is dose-
dependent,depends on a combined effect on the synthe-
sis and release of 5-HT and the stimulation of postsynap-
tic 5-HT receptors (ie,5-HT1A or 5-HT2A/2C receptors,or
both), without defining which 5-HT receptor subtypes
might be dysregulated.In this context,it is conceivable that
altered 5-HT1A receptor function by glucocorticoids—
although not unanimously found in depression
14—may be
compensated by increased 5-HT turnover and 5-HT2
receptor activity,therefore leading to normal responses to
d-FEN test.
In fact,even if the hypothesis of hypercortisolism leading
to reduced 5-HT function had been confirmed, this
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Table II. Demographic characteristics and biological data for depressed patients according to their history suicide attempt. HDRS, Hamilton Depression
Rating Scale score (17-item); DST, dexamethasone suppression test; No. of abnormal DSTs, number of subjects with highest post-DST corti-
sol level >130 nmol/L; ∆, peak concentration minus baseline value; PRL, prolactin; ACTH, adrenocorticotropic hormone.
History of suicide attempt (n=40) No history of suicide attempt (n=31) P
Mean (SEM) Mean (SEM)
Age (years) 40.7 (1.4) 39.5 (1.8) 0.50
Range (years) 19-58 19-60
Gender (M/F) 17/23 11/20 0.36
Weight (kg) 66.3 (1.9) 62.8 (1.4) 0.24
Range (kg) 42-93 43-85
HDRS 27.7 (0.8) 26.7 (1.6) 0.17
Range 18-38 18-36
Post-DST cortisol (nmol/L) 108 (19) 84 (12) 0.93
No. of abnormal DSTs 12 7 0.33
Fenfluramine test
• Baseline PRL (µg/L) 13.4 (1.4) 16.1 (1.7) 0.30
• ∆PRL (µg/L) 0.7 (0.9) 8.9 (2.6) 0.0001
• Baseline ACTH (ng/L) 27.9 (3.1) 20.8 (2.3) 0.07
• ∆ACTH (ng/L) 6.4 (1.7) 10.4 (2.0) 0.05
• Baseline cortisol (nmol/L) 383 (31) 372 (25) 0.85
• ∆Cortisol (nmol/L) 48 (21) 128 (28) 0.02Basic research
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Figure 1. Serum prolactin levels before and after administration of 45 mg d-fenfluramine hydrochloride in 20 control subjects and 60 depressed patients
classified according to the presence (∆∆TSH+, n=49) or absence (∆∆TSH-, n=11) of hyperthalamic-pituitary-thyroid axis dysregulation.
17 The
histograms (±SEM) represent the mean maximum increment in serum prolactin level above baseline (∆Prolactin). P values are obtained by
Mann-Whitney two-tailed U test corrected by Bonferroni’s method for three pairwise comparisons. ∆∆TSH, difference in thyroid-stimulating
hormone response between 11 PM and 8 AM thyrotropin-releasing hormone tests. 
Reproduced from reference 17: Duval F, Mokrani MC, Bailey P, et al. Thyroid axis activity and serotonin function in major depressive episode. Psychoneuroendocrinology. 1999;24:695-712.
Copyright © 1999, Elsevier Science Group.
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(n=20) (n=49) (n=11)hypothesis would not have clarified why about two thirds
of patients with a history of suicidal behavior had not
exhibited hypercortisolism. One may argue that hyper-
cortisolism could be associated with a specific form of sui-
cidal behavior (ie,violent,although studies on this topic
are conflicting);but considering hypercortisolism as etio-
logical may be restrictive since HPA axis hyperactivity is
not specific to a particular psychiatric diagnosis.
Increased HPT axis activity as a compensatory
mechanism for diminished 5-HT function in
depressed patients
Hypothalamic-pituitary-thyroid (HPT) axis activity is
altered in a substantial proportion of depressed patients.
It is generally accepted that approximately one quarter of
euthyroid depressed patients have a blunted thyrotropin
(thyroid-stimulating hormone,TSH) response to morning
administration of protirelin (thryotropin-releasing hor-
mone,TRH).
15We have reported that the 11 PMTRH test
(200 µg,intravenous [IV]) is more sensitive than the 8 AM
TRH test, and that the difference in TSH response
between 11 PM and 8 AMTRH tests (∆∆TSH) is an even
more sensitive measure: this chronobiological index is
reduced in about 70% of inpatients with major depres-
sion.
16 It has been suggested that blunted TRH-induced
TSH stimulation might reflect a downregulation of the
TRH receptors in the pituitary gland secondary to a pro-
longed increase in hypothalamic TRH stimulation.
15
On the basis of recent animal studies,the effects of 5-HT
on the central regulation of TRH secretion are believed to
be predominantly inhibitory.According to this assumption,
a reduced 5-HT function could lead to hypersecretion of
TRH,and therefore to blunted TSH response to TRH in
depression.
However,when depressed patients are classified on the
basis of their ∆∆TSH test status, patients with reduced
∆∆TSH values (≤2.5 µU/mL) have hormonal d-FEN
responses comparable to those of controls. Conversely,
patients with normal ∆∆TSH values (ie,without HPT axis
abnormality) show lower PRL and cortisol responses to 
d-FEN than controls and patients with abnormal ∆∆TSH
values (Figure 1).
17ACTH response to d-FEN—which cor-
related with cortisol (r=0.66;n=80;P<0.00001) and PRL
(r=0.41; n=80; P<0.0003) response—is also lower in
patients without HPT axis abnormality when compared
with controls (P<0.009) and patients with HPT dysfunc-
tion (ie,reduced ∆∆TSH values;P<0.0002).
Thus, patients with normal HPT axis activity exhibit
reduced PRL and ACTH/cortisol responses compatible
with a 5-HT deficit. On the other hand, patients with
abnormal HPT axis activity show a level of 5-HT func-
tion comparable to that found in healthy subjects.
Therefore,according to the TRH hypothesis,
15 one may
hypothesize that TRH overactivity,which produces both
pituitary TRH receptor downregulation and direct acti-
vation of the thyroid gland,
18,19 could also stimulate 5-HT
activity.Indeed,it has been found in animal studies that
(i) TRH stimulates 5-HT neurotransmission via 5-HT1
receptors;and (ii) thyroid hormones enhance 5-HT activ-
ity in certain brain areas (such as the cerebral cortex).
Furthermore,the reduced central 5-HT activity found in
patients with hypothyroidism is reversed by thyroxine
replacement therapy.
20 In the context of major depres-
sion, the effects of increased HPT axis hormones (ie,
increased secretion of TRH and elevated circulating con-
centrations of thyroid hormones well within the physio-
logical range
19) may be regarded as a compensatory
mechanism in order to correct reduced central 5-HT
activity.
Schematically,one may define two situations (Figure 2):
•The compensatory mechanisms are effective;in this case
a signal (such as a decrease in 5-HT function) leads to
a series of biological modifications (such as an increase
in thyroid axis activity). These modifications may be
Serotonin and HPA and HPT axes in depression - Duval et al Dialogues in Clinical Neuroscience - Vol 4 . No.4 . 2002
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Figure 2. A. When the compensatory mechanisms are effective, a
decrease in the serotonin (5-hydroxytryptamine, 5-HT) function
leads to an increase in thyroid axis activity. B. When the com-
pensatory mechanisms are not effective, the 5-HT dysfunction
remains. In depressed patients with a history of suicidal behav-
ior, 5-HT alteration may be understood as a failure of the com-
pensatory mechanism. TRH, thyrotropin-releasing hormone;
TSH, thyroid-stimulating hormone; N, normal.
A
TRH
B
Stimulation
Inhibition
TRH
TSH TSH
5-HT 5-HT
N
5-HTunderstood as a repairing process aiming to restore an
efficient 5-HT functioning.
•The compensatory mechanisms are not effective;in this
case the 5-HT dysfunction remains.In depressed patients
with a history of suicidal behavior,5-HT alteration may
be understood as a failure of the compensatory mecha-
nisms.
Interactions between the dopaminergic 
system and the HTP axis in depression
Given the interactions between dopamine (DA) and HPT
and 5-HT, one may hypothesize that DA may also be
involved in the compensatory mechanisms. It is known
that the mesolimbic DA system plays a key role in goal-
directed and motivational behavior.In depression,it has
been suggested that hypofunction in mesolimbic DA sys-
tem may be involved in anhedonia and amotivational apa-
thy.
21 DA agonists can facilitate the action of antidepres-
sant drugs in certain animal models of depression and in
some depressed patients.
While at the hypothalamic level the interregulations of
DA and 5-HT systems are complex and not fully under-
stood,preclinical studies have shown that dopamine D2
receptors stimulate the release of hypothalamic TRH
and inhibit TSH production at the pituitary level. In
turn,TRH and thyroid hormones stimulate the DA sys-
tem,and induce a downregulation of D2 receptors.
To examine the functional relationships between HPT axis
activity and DA function in depressed patients,especially
in those with a history of suicidal behavior,we measured
hormonal responses to 8 AM and 11 PMTRH tests and to
apomorphine (APO) test in 64 drug-free inpatients with
DSM-IV
12 major depression (35 with a history of suicide
attempt,29 without) and 34 hospitalized healthy controls.
APO,a direct-acting DA agonist with high affinities for D2
and D3 receptors and a partial agonist at the D1 receptor,
decreases PRL and stimulates growth hormone (GH),
ACTH,and cortisol secretion.
22
Compared with controls,patients demonstrate lower TRH
and TSH responses and lower APO-induced PRL sup-
pression (Table III).PRL response to APO provides an
indirect index of central neurotransmission by assessing
postsynaptic D2 receptor sensitivity at the pituitary level.
A lower PRL response to APO may reflect a decreased
D2 receptor function.This abnormality may represent (i)
a primary deficit in D2 receptor sensitivity in the pituitary
in depressed patients;or (ii) a downregulation of D2 recep-
tors secondary to increased presynaptic DA activity.
Cooccurrence of HPT axis and tuberoinfundibular DA
Basic research
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Table III. Demographic characteristics and biological data for depressed patients and normal control subjects. ∆, peak concentration minus baseline
value; TRH, thyrotropin-releasing hormone; TSH, thyroid-stimulating hormone; PRL, prolactin; PRL suppression = (PRLAUC/baseline PRLAUC)×100;
GH, growth hormone; ACTH, adrenocorticotropic hormone.
Control (n=34) Depressed patients (n=64) P
Mean (SEM) Mean (SEM)
Age (years) 37.7 (1.6) 40.4 (1.4) 0.24
Gender (M/F) 14/20 32/32 0.52
TRH tests
• 8 AM baseline TSH (µU/mL) 1.20 (0.09) 0.94 (0.06) 0.007
• 8 AM ∆TSH (µU/mL) 8.43 (0.57) 6.21 (0.41) 2.3 10-4
• 11 PM baseline TSH (µU/mL) 1.19 (0.11) 0.80 (0.05) 0.002
• 11 PM ∆TSH (µU/mL) 12.34 (0.65) 8.06 (0.50) 4.7 10-7
• ∆∆TSH (µU/mL) 3.9 (0.25) 1.83 (0.27) 1.1 10-7
Apomorphine test
• Baseline PRL (µg/L) 10.6 (0.9) 13.3 (1.0) 0.18
• PRL suppression (%) 39.5 (1.5) 28.5 (2.0) 1.2 10-4
• Baseline GH (ng/mL) 0.4 (0.3) 0.3 (0.2) 0.88
• ∆GH (ng/mL) 12.3 (1.6) 12.5 (1.2) 0.89
• Baseline ACTH (ng/L) 26.5 (3.1) 28.1 (2.3) 0.55
• ∆ACTH (ng/L) 61.5 (19.0) 50.1 (11.6) 0.94
• Baseline cortisol (nmol/L) 305 (17) 283 (15) 0.33
• ∆Cortisol (nmol/L) 175 (31) 117 (17) 0.15dysregulation is compatible with a decreased TRH and D2
receptor function,possibly secondary to increased TRH
tone,since TRH stimulates the DA system and induces a
downregulation of D2 receptors.
When classifying patients according to their history of sui-
cidal behavior, those with a negative history more fre-
quently have reduced ∆∆TSH values (Figure 3),but com-
parable hormonal APO responses (ie,PRL,ACTH,and
cortisol), than those with a positive history. In patients
without a history of suicide attempt,a negative correlation
is found between ∆∆TSH values and post-APO ACTH
(ρ=-0.44,P=0.02) and cortisol (ρ=-0.50,P<0.008) levels.
This correlation is found neither in patients with a history
of suicide attempt (Figure 4) nor in control subjects.
The finding of a negative correlation between ∆∆TSH
and post-APO ACTH and cortisol values in patients
without a history of suicidal behavior is rather paradox-
ical.Owing to the regulations between HPT and DA sys-
tems,one could have expected a positive correlation and
not a negative one (ie, an increase in TRH secretion
should have led to a decrease in D2 function).Whether
hypofunctionality of D2 receptors exists on both hypo-
thalamic and pituitary levels,the absence of GH,ACTH,
and cortisol response to APO in depression would sug-
gest an upregulation of other DA receptor subtypes
Serotonin and HPA and HPT axes in depression - Duval et al Dialogues in Clinical Neuroscience - Vol 4 . No.4 . 2002
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Figure 3. Differences between 11 PM and 8 AM maximum increments in
thyroid-stimulating hormone (∆∆TSH) in controls and in
depressed patients with a suicidal history (SH) and without an
SH. Blunted ∆∆TSH, defined as a response below 2.5 µU/mL,
is more frequent in patients without SH (n=23 [80%]) than in
patients with (n=19 [54%]) (P=0.03 by Fisher’s exact test).
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positive suicide history (n=35)(such as D1) in the hypothalamus.Indeed,GH,ACTH,
and cortisol response to APO reflects primarily stimula-
tion of the hypothalamic releasing hormones (GH-
releasing hormone and CRH,respectively) rather than a
direct effect on the pituitary.Moreover,cortisol response
to APO, which is correlated to ACTH (ρ=0.74; n=98;
P<0.00001),can be considered as an index of central DA
function connected with the regulation of the HPA axis.
Thus,the negative correlation between ∆∆TSH and post-
APO ACTH and cortisol values in patients without a his-
tory of suicidal behavior suggests that the efficacy of
compensatory mechanisms requires a new functional bal-
ance between HPT and DA systems.
In the depressed group with a history of suicidal behavior,
the absence of a functional link between HPT and DA
activity in the hypothalamus may play a role in the patho-
physiology of suicidal behavior.However,one may note
that half of the patients of this group showed HPT and DA
functional adjustment (Figure 4; ie, those exhibiting
blunted ∆∆TSH values),suggesting that this requirement
is not sufficient in the efficacy of compensatory mecha-
nisms.In other words,other processes—so far unknown—
are also involved in the efficacy of compensatory mecha-
nisms.
Conclusions
Taken together our findings in depressed inpatients sug-
gest that:
• HPA axis hyperactivity is not responsible for the reduced
5-HT activity found in patients with a history of suicidal
behavior.
• HPT dysregulation may be regarded as a compensatory
mechanism for diminished central 5-HT activity.
• Cooccurrence of HPT axis and tuberoinfundibular DA
dysregulation is compatible with a decreased TRH and
D2 receptor function (possibly secondary to increased
TRH tone).
•The absence of a functional link between HPT and DA
activity in the hypothalamus may be implicated in the
pathogenesis of suicidal behavior.
A better knowledge of processes involved in the efficacy
of compensatory mechanisms could lead to new thera-
peutic strategies in patients with recurrent major depres-
sive disorder, especially those with a history of suicidal
behavior.❏
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La interacción entre el sistema 
serotoninérgico y los ejes HHA e HHT en
pacientes con depresión mayor: importancia
para la patogénesis de la conducta suicida
Las alteraciones en el sistema serotoninérgico 
(5-hidroxitriptamina, 5-HT) constituyen la anorma-
lidad neurobiológica más consistentemente asociada
con el suicidio. Esta anormalidad podría constituir un
marcador de vulnerabilidad que predispusiera a los
sujetos a conductas autoagresivas e impulsivas. Sin
embargo, también han sido descritas otras anorma-
lidades en víctimas de suicidio como la hiperactivi-
dad del eje hipotálamo-hipófisis-adrenal (HHA).
Mientras que en animales se han observado los efec-
tos inhibitorios de los adrenocorticosteroides en la
función del receptor 5-HT1A, en pacientes depresivos
con una historia de conductas suicidas la hiperactivi-
dad del eje HHA no parece ser responsable de la
reducción de la actividad serotoninérgica. Por otra
parte, la disfunción del eje hipotálamo-hipófisis-
tiroides (HHT), que se observa con frecuencia en la
depresión, puede representar una respuesta com-
pensatoria a la reducción de la neurotransmisión
central de serotonina. Sin embargo, en pacientes
depresivos con una historia de conductas suicidas,
la ausencia de una relación funcional entre la acti-
vidad HHT y la dopamina a nivel del hipotalámo
puede estar involucrada en la fisiopatología de la
conducta suicida. Se requiere de futuras investiga-
ciones para determinar por qué los mecanismos
compensatorios no son eficientes en pacientes con
conductas suicidas.
Interactions entre le système 
sérotoninergique et les axes HHS et HHT
chez des patients atteints de dépression
majeure : implications pour la pathogenèse
du comportement suicidaire
Les perturbations du système sérotoninergique 
(5-hydroxytryptamine, 5-HT) constituent l’anomalie
neurobiologique la plus régulièrement associée au
suicide. Cette anomalie pourrait être un marqueur
de vulnérabilité prédisposant des individus à déve-
lopper un comportement autoagressif et impulsif.
Cependant, d’autres anomalies, comme l’hyperacti-
vité de l’axe hypothalamo-hypophyso-surrénalien
(HHS), ont aussi été décrites chez des victimes de sui-
cide. Alors que les effets inhibiteurs des hormones
corticosurrénales sur la fonction du récepteur 5-HT1A
ont été montrés chez l’animal, l’hyperactivité de l’axe
HHS ne semble pas responsable de l’activité 5-HT
réduite retrouvée chez les patients déprimés et ayant
des antécédents de comportement suicidaire. Par
ailleurs, le dysfonctionnement de l’axe hypothalamo-
hypophyso-thyroïdien (HHT), fréquemment observé
dans la dépression, pourrait représenter une réponse
compensatrice pour restaurer la neurotransmission
centrale 5-HT. De plus, chez les patients déprimés
ayant des antécédents de comportement suicidaire,
l’absence de lien fonctionnel entre l’HHT et l’activité
dopaminergique au niveau hypothalamique pour-
rait être impliquée dans la physiopathologie du
comportement suicidaire. Des recherches sont néces-
saires à l’avenir pour déterminer la raison pour
laquelle les mécanismes compensateurs ne sont pas
efficaces chez les patients suicidaires.